MYEOV and breast cancer: Furthermore, among 150 breast cancer risk regions identified by genome-wide association studies [112], several ERGs identified in this study (BARX2, CBX6, KCNN4, MYEOV, PDZK1 in 300 ERGs) were included as the targets for cancer drivers, transcription factors, and signaling proteins.